Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Item
http://www.wikidata.org/entity/Q34349343
Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccineSelection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horsesEnvelope determinants of equine lentiviral vaccine protection.Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread.Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.Envelope variation as a primary determinant of lentiviral vaccine efficacy.Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.Genetic Evolution during the development of an attenuated EIAV vaccineInfluence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
P2860

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Item
http://www.wikidata.org/entity/Q34349343
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Equine infectious anemia virus ...... ation as a dominant phenotype.
@ast
Equine infectious anemia virus ...... ation as a dominant phenotype.
@en
Equine infectious anemia virus ...... ation as a dominant phenotype.
@nl
type
label
Equine infectious anemia virus ...... ation as a dominant phenotype.
@ast
Equine infectious anemia virus ...... ation as a dominant phenotype.
@en
Equine infectious anemia virus ...... ation as a dominant phenotype.
@nl
prefLabel
Equine infectious anemia virus ...... ation as a dominant phenotype.
@ast
Equine infectious anemia virus ...... ation as a dominant phenotype.
@en
Equine infectious anemia virus ...... ation as a dominant phenotype.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Equine infectious anemia virus ...... zation as a dominant phenotype
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.76.21.10588-10597.2002
P407
P433
P478
P50
P577
P5875
P698
P921
P932